Outcomes of eltrombopag treatment and development of iron deficiency in children with immune thrombocytopenia in Turkey [İmmün trombositopenili çocuk hastalarda eltrombopag tedavisi ve tedaviye bağlı demir eksikliği]

dc.contributor.author	Yozgat, A.K.
dc.contributor.author	Leblebisatan, G.
dc.contributor.author	Akbayram, S.
dc.contributor.author	Özel, S.Ç.
dc.contributor.author	Karakaş, Z.
dc.contributor.author	Erduran, E.
dc.contributor.author	Yılmaz, Ş.
dc.contributor.author	Koçak, Ü.
dc.contributor.author	Ünal, Ş.
dc.contributor.author	Özdemir, G.N.
dc.contributor.author	Albayrak, M.
dc.date.accessioned	2021-12-21T08:40:49Z
dc.date.available	2021-12-21T08:40:49Z
dc.date.issued	2020
dc.identifier.issn	13007777
dc.identifier.uri	https://doi.org/10.4274/tjh.galenos.2020.2019.0380
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1211
dc.description.abstract	Objective: Immune thrombocytopenia (ITP) is a rare autoimmune disease and hematologic disorder characterized by reduced platelet counts that can result in significant symptoms, such as bleeding, bruising, epistaxis, or petechiae. The thrombopoietin recept
dc.language.iso	English
dc.publisher	Turkish Society of Hematology
dc.rights	All Open Access, Bronze, Green
dc.title	Outcomes of eltrombopag treatment and development of iron deficiency in children with immune thrombocytopenia in Turkey [İmmün trombositopenili çocuk hastalarda eltrombopag tedavisi ve tedaviye bağlı demir eksikliği]
dc.type	Article
dc.relation.journal	Turkish Journal of Hematology
dc.identifier.issue	3
dc.identifier.startpage	139
dc.identifier.endpage	144
dc.identifier.volume	37
dc.identifier.doi	10.4274/tjh.galenos.2020.2019.0380
dc.relation.issue	3
dc.relation.volume	37